62 related articles for article (PubMed ID: 28058595)
1. Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression.
Lee Y; Chowdhury T; Kim S; Yu HJ; Kim KM; Kang H; Kim MS; Kim JW; Kim YH; Ji SY; Hwang K; Han JH; Hwang J; Yoo SK; Lee KS; Choe G; Won JK; Park SH; Lee YK; Shin JH; Park CK; Kim CY; Kim JI
Exp Mol Med; 2024 Apr; 56(4):975-986. PubMed ID: 38609519
[TBL] [Abstract][Full Text] [Related]
2. FGFR families: biological functions and therapeutic interventions in tumors.
Liu Q; Huang J; Yan W; Liu Z; Liu S; Fang W
MedComm (2020); 2023 Oct; 4(5):e367. PubMed ID: 37750089
[TBL] [Abstract][Full Text] [Related]
3. CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.
Fu H; Zhang Y; Chen Y; Chen J; Chen P
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200803
[TBL] [Abstract][Full Text] [Related]
4. Interaction of FGF9 with FGFR3-IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma.
Paur J; Valler M; Sienel R; Taxauer K; Holzmann K; Marian B; Unterberger A; Mohr T; Berger W; Gvozdenovich A; Schimming J; Grusch M; Grasl-Kraupp B
Liver Int; 2020 Sep; 40(9):2279-2290. PubMed ID: 32378800
[TBL] [Abstract][Full Text] [Related]
5. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.
Li X; Wu Y; Suo P; Liu G; Li L; Zhang X; Chen S; Xu M; Song L
Medicine (Baltimore); 2020 Jan; 99(5):e19076. PubMed ID: 32000458
[TBL] [Abstract][Full Text] [Related]
7. Genetic profiling of hepatocellular carcinoma using next-generation sequencing.
Schulze K; Nault JC; Villanueva A
J Hepatol; 2016 Nov; 65(5):1031-1042. PubMed ID: 27262756
[TBL] [Abstract][Full Text] [Related]
8. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
Yan X; Shao C; Chen C; Chen J; Gu S; Huang L; Fu X; Zhao H; Qiu Y
Dig Dis Sci; 2017 Feb; 62(2):407-417. PubMed ID: 28058595
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.
Qiu WH; Zhou BS; Chu PG; Chen WG; Chung C; Shih J; Hwu P; Yeh C; Lopez R; Yen Y
World J Gastroenterol; 2005 Sep; 11(34):5266-72. PubMed ID: 16149130
[TBL] [Abstract][Full Text] [Related]
10. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
[TBL] [Abstract][Full Text] [Related]
11. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
13. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.
Vilarinho S; Erson-Omay EZ; Mitchell-Richards K; Cha C; Nelson-Williams C; Harmancı AS; Yasuno K; Günel M; Taddei TH
J Hepatol; 2017 Jul; 67(1):186-191. PubMed ID: 28323122
[TBL] [Abstract][Full Text] [Related]
14. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
[TBL] [Abstract][Full Text] [Related]
15. FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
Liu X; Jing X; Cheng X; Ma D; Jin Z; Yang W; Qiu W
Med Oncol; 2016 May; 33(5):46. PubMed ID: 27044356
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]